Active, not recruitingPhase 4NCT06240351

A Study to Evaluate the Safety and Efficacy of Baricitinib in the Treatment of Frontal Fibrosing Alopecia (FFA)

Studying Alopecia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Alabama at Birmingham
Principal Investigator
Boni Elewski, MD
University of Alabama at Birmingham
Intervention
Baricitinib 4 MG Oral Tablet(drug)
Enrollment
15 enrolled
Eligibility
18-90 years · FEMALE
Timeline
20242027

Study locations (1)

Collaborators

Eli Lilly and Company

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06240351 on ClinicalTrials.gov

Other trials for Alopecia

Additional recruiting or active studies for the same condition.

See all trials for Alopecia

← Back to all trials